Market Overview

MGC DIAGNOSTICS CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout


Rigrodsky & Long, P.A.:

  • Do you own shares of MGC Diagnostics Corporation (NASDAQ CM: MGCD)?
  • Did you purchase any of your shares prior to November 27, 2017?
  • Do you think the proposed buyout is fair?
  • Do you want to discuss your rights?

& Long, P.A.
announces that it is investigating potential legal
claims against the board of directors of MGC Diagnostics Corporation
("MGCD" or the "Company") (NASDAQ CM: MGCD)
regarding possible breaches of fiduciary duties and other violations of
law related to the Company's entry into an agreement to be acquired by
affiliates of Altus Capital Partners, Inc. ("Altus") in a transaction
valued at approximately $50.3 million. Under the terms of the agreement,
shareholders of MGCD will receive $11.03 in cash for each share of MGCD
common stock.

If you own common stock of MGCD and purchased any shares before November
27, 2017, if you would like to learn more about this investigation, or
if you have any questions concerning this announcement or your rights or
interests, please contact Seth D. Rigrodsky or Gina M. Serra at
Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, DE
19803, by telephone at (888) 969-4242, or by e-mail at

& Long, P.A.
, with offices in Wilmington, Delaware and Garden
City, New York, regularly prosecutes securities
fraud, shareholder corporate, and shareholder derivative litigation

on behalf of shareholders in state and federal courts throughout the
United States.

Attorney advertising. Prior results do not guarantee a similar outcome.

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial